---
id: imiquimod-mechanism_266
category: antimicrobials
tags: [antivirals, imiquimod, immune-response-modifier, TLR7, HPV, warts]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Imiquimod: Immune Response Modifier

**Q:** What is the mechanism of action of imiquimod for treating genital warts, and what are its clinical indications?

**A:**

**Mechanism (NO direct antiviral activity):**
- **TLR-7 agonist** (Toll-like receptor 7) → activates innate immunity
- Induces cytokines: **IFN-α, TNF-α, IL-6, IL-1, IL-8**
- Activates immune cells:
  - **Langerhans cells** → migrate to lymph nodes → activate adaptive immunity
  - **NK cells, macrophages, B-lymphocytes**

**Result:** Local immune response → wart regression (not direct viral killing)

**Clinical Indications (topical 5% cream):**
- **External genital/perianal warts** (HPV-induced condyloma acuminata)
- **Actinic keratosis**
- **Superficial basal cell carcinoma**

**Dosing (genital warts):**
- Apply 3× weekly at bedtime, wash off after 6-10 hours
- Continue until warts clear (max 16 weeks)

**Key Pearl:** Works through **immune activation**, not direct antiviral effects → can cause local inflammation (erythema, erosion).

**Media:**

**Sources:** [PMC105543 - Imiquimod for Genital Warts], [DrugBank Imiquimod DB00724], [JAAD Treatment of Genital Warts 1998], [Antiviral Research Enhancement of Immune Response 1999]
